{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:26:29Z","timestamp":1756383989292},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T00:00:00Z","timestamp":1384128000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0080187","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T23:28:46Z","timestamp":1384212526000},"page":"e80187","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictive Factors of Herpes Zoster HIV-Infected Patients: Another Adverse Effect of Crack Cocaine"],"prefix":"10.1371","volume":"8","author":[{"given":"Mathieu","family":"Nacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Basurko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Adenis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Gaubert-Marechal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Mosnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Edouard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Vantilcke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindou","family":"Sivapregassam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Tressi\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Cabi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Couppi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,11,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJM199009063231002","article-title":"Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia","volume":"323","author":"R Mahalingam","year":"1990","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/infdis\/166.5.1153","article-title":"Herpes zoster and human immunodeficiency virus infection","volume":"166","author":"SP Buchbinder","year":"1992","journal-title":"J Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/clinids\/23.5.990","article-title":"Herpes zoster and progression to AIDS in a cohort of individuals who seroconverted to human immunodeficiency virus. Italian HIV Seroconversion Study","volume":"23","author":"MB Alliegro","year":"1996","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/infdis\/168.5.1264","article-title":"Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group","volume":"168","author":"MJ Glesby","year":"1993","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/168.1.245","article-title":"Herpes zoster and human immunodeficiency virus infection: a cohort study of 101 coinfected patients. Groupe d'Epidemiologie clinique du SIDA en aquitaine","volume":"168","author":"AM Rogues","year":"1993","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00002030-199510000-00006","article-title":"Herpes zoster, immunological deterioration and disease progression in HIV-1 infection","volume":"9","author":"J Veenstra","year":"1995","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1086\/315146","article-title":"Zoster incidence in human immunodeficiency virus-infected hemophiliacs and homosexual men, 1984-1997. District Of Columbia Gay Cohort Study. Multicenter Hemophilia Cohort Study","volume":"180","author":"EA Engels","year":"1999","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1086\/515019","article-title":"High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors","volume":"27","author":"E Mart\u00ednez","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9343(01)00703-3","article-title":"Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection","volume":"110","author":"P Domingo","year":"2001","journal-title":"Am J Med"},{"key":"ref10","first-page":"1719","article-title":"Herpes zoster infection in HIV-seropositive patients associated with highly active antiretroviral therapy","volume":"12","author":"T Aldeen","year":"1998","journal-title":"AIDS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort","volume":"42","author":"I Ratnam","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.4049\/jimmunol.138.4.1229","article-title":"Analysis of immune function in herpes zoster patients: demonstration and characterization of suppressor cells","volume":"138","author":"R Cauda","year":"1987","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00042560-199612010-00004","article-title":"CD8+ lymphocyte responses to antiretroviral therapy of HIV infection","volume":"13","author":"A Carr","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jinf.2010.04.004","article-title":"Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults","volume":"61","author":"J Molton","year":"2010","journal-title":"J Infect"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAI.0b013e318266cd3c","article-title":"Herpes zoster among persons living with HIV in the current antiretroviral therapy era","volume":"61","author":"LJ Blank","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.qai.0000178408.62675.b0","article-title":"The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era","volume":"40","author":"KA Gebo","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1542\/peds.2007-0564","article-title":"Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006","volume":"121","author":"SM Wood","year":"2008","journal-title":"Pediatrics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/cid\/cit165","article-title":"Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era","volume":"57","author":"A Moanna","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/QAD.0b013e328308de33","article-title":"HIV immune reconstitution syndrome in sub-Saharan Africa","volume":"22","author":"DM Murdoch","year":"2008","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11481-006-9023-5","article-title":"Drugs of abuse, immune modulation, and AIDS","volume":"1","author":"GA Cabral","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/QAD.0b013e32833147c2","article-title":"Crack cocaine use increases the incidence of AIDS-defining events in French Guiana","volume":"23","author":"M Nacher","year":"2009","journal-title":"AIDS"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0080187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T11:02:03Z","timestamp":1688641323000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0080187"}},"subtitle":[],"editor":[{"given":"Qiliang","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,11]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0080187","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,11]]}}}